logo

ABVX

Abivax·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ABVX fundamentals

Abivax (ABVX) expects to report earnings on Dec 15, 2025, with estimated revenue of 1.30M (YoY 0.00%), and EPS at -0.7 (YoY 0.00%).
Revenue estimate / YoY
1.30M
0.00%
EPS estimate / YoY
-0.7
0.00%
Report date
Dec 15, 2025
EPS
Revenue

Revenue & Expenses

ABVX has released its 2025 Q2 earnings report, with revenue of 1.29M, reflecting a YoY change of -78.66%, and net profit of -56.98M, showing a YoY change of -37.22%. The Sankey diagram below clearly presents ABVX's revenue sources and cost distribution.

Key Indicators

Abivax (ABVX) key financial stats and ratios, covering profitability, financial health, and leverage.
Abivax (ABVX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Abivax (ABVX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Abivax (ABVX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Abivax (ABVX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Abivax (ABVX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield